BioSpace News Archive

The powder finished dosage form is made in the U.S.A. and packaged in bottles providing 60 mL of usable volume after constitution.

In addition, Merck scientists will present data from experiments investigating the mechanisms of formation and maintenance of HIV reservoirs and the impact of HIV persistence in the gut on immune recovery during antiretroviral therapy.

Health care system credited for inspiring patients with disabilities to achieve their dreams.

Automation technology applies AI to RTLS, EHR and other data to streamline patient flow, reduce wait times and improve throughput in hospitals.

Global Phase 3 study to enroll approximately 100 patients with the most common genetic form of the disease.

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its fourth quarter and full year 2017 financial results and operational progress on Thursday, March 8, 2018, after the close of the U.S. financial markets.

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX) today announced that the company’s Chief Executive Officer Michael D. West, Ph.D. will participate at three upcoming conferences: the Mauldin Economics Strategic Investment Conference, March 6-9 in San Diego; Undoing Aging, March 15-17 in Berlin, Germany; and the 10th World Congress and Expo on Cell & Stem Cell Research, March 19-21 in New York City.

Preclinical studies find levosimendan improves right heart function; Beneficial treatment for right heart failure secondary to pulmonary hypertension

Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, has entered into a new secured credit facility with Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors.

Purdue Pharma L.P. today announced that Marcelo Bigal, MD, PhD has been appointed Chief Medical Officer (CMO).